Richard Freeman, founder and CEO, gave us a look into his background and how Medi2data has pivoted for success during the global pandemic, and beyond.
About Medi2data:
Medi2data builds innovative, easy-to-use technologies allowing GP practices to quickly and securely share consented patient information.
eMR, is Medi2data’s free flagship software, enabling GP practices to digitally create high-quality, GDPR-compliant Subject-to-Access Requests (SARs) and third-party medical reports in minutes.
eMR+ has all the benefits of eMR, but is outsourced to the Medi2data team, removing all the hassle of medical reporting for practices while generating an income.
You’ve founded businesses, been acquired, and had a career in the corporate world. What made you want to do it all again with Medi2data?
I’ve always felt more comfortable being in control of my destiny and found that my strengths are more impactful in smaller, more agile organisations. I like to create meaningful propositions that address specific problems or make life easier for people and take great satisfaction in bringing them to life.
When GDPR came into force in May 2018, the Medi2data team immediately recognised the enormous negative impact this was having on GP practices. So we created eMR to help primary care deal with the GDPR impact.
The NHS is under significant financial pressure, so it gives me great pride to provide an amazing time-saving product to GP practices for free.
What would you say has been Medi2data’s most significant achievement to date?
Medi2data has brought simplicity to a very complex sector. The primary care sector in the United Kingdom is difficult to penetrate. Something that works so well and had such positive feedback shows that we’ve delivered something of meaning and impact. Our greatest achievement to date was to deliver what we set out to try and achieve.
eMR allows GPs to give patients secure access to their data. This gives patients secure access to their data and frees up time for GPs. Riding on the success of eMR, our next project with MOHARA is My Health Wallet, which allows patients to take control of their data.
You mention partners quite prominently on your website – why are partners so important to Medi2data?
Our clinical and academic partners, such as MOHARA and the University of Swansea, have been instrumental in our success. We’re an affiliate of the university. That association gave us credibility in the early days around the designing and building of eMR. The university is involved in the development of My Health Wallet, too. They give us the health/medical law input on how we design the application, protecting and safeguarding the patient.
Our AWS partnership opens up opportunities around how data can be more securely transmitted. They give us access to ground-breaking tools, such as Quantum Ledger Databases (QLDB), that wouldn’t be readily available to us otherwise.
Through our partnerships, we have access to other sectors and disciplines. Our ecosystem has expanded through the association of partnerships as well, carrying huge benefits. I am a team player. I recognise where my skill sets end and draw upon my fantastic team to fill those gaps. That’s how I view partnerships from a business perspective as well. And socially, it is great to have partnerships. It adds a different dimension to the working day.
Next week will be the second part of our three-part series with Medi2data. We’ll cover how Medi2data navigated their way through the pandemic – be sure not to miss it!
